AAM Access 2018 Chip Davis State of AAM Address @accessiblemeds
AAM Access 2018 Chip Davis State of AAM Address  @accessiblemeds
Uploaded February 2018 | Updated November 2026, 3 hours ago
At Access! 2018, AAM CEO Chip Davis urged the executives of member companies to engage proactively with state and federal legislators to help them understand the value proposition of generics and biosimilars and how our business model differs from that of the brand-name manufacturers.

“We have 90 percent of the market share versus the brand-name industry,” Chip continued, “but in terms of mind share those ratios are flipped, and they leverage that mind share very effectively.” He described how Big Pharma deflects attention away from itself, pointing fingers at insurers, pharmacy benefit managers and hospitals.
AAM Access 2018 Chip Davis State of AAM AddressAAM All Access - Thomas TighePeople are talking about GRx+Biosims – don’t miss out!Chip Davis on Panel: Opioid Epidemic: Youth Awareness & PreventionAAM Member Sandoz: Keren HaruviHelens Story — She Knows She Can Rely on BiosimilarsGPhA President & CEO Chip Davis 2016 Annual Meeting Keynote AddressAAM Interim CEO Jeff Francer: New Opportunities at the GRx+Biosims 2020 Virtual ConferenceSave the Date for Access 2019 - Heading to New Orleans! [widescreen]Apotex President and CEO Jeff Watson - AAM Chair’s Address at Access! 2018AAM Access! 2020 —A New Experience in the Nation’s CapitalAAM All Access Promo: Bob Pollock
Association for Accessible Medicines |

AAM Access 2018 Chip Davis State of AAM Address

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER